|
Subject
|
Sex
|
Side
|
Largest nodule on U/S (cm) and side
|
Final pathology
|
Adverse pathological features
|
|---|
|
1
|
F
|
R
|
2.4 (right)
|
Medullary CA
| |
|
2
|
M
|
L
|
1 (left)
|
Micropapillary CA
|
ETE
|
|
3
|
M
|
L
|
1.2 (left)
|
Micropapillary CA
| |
|
4
|
M
|
L
|
1.2 (left)
|
Papillary CA
| |
|
5
|
F
|
R
|
1.4 (right)
|
Follicular adenoma
| |
|
6
|
M
|
R
|
1.6 (left)
|
Papillary CA
| |
|
7
|
F
|
L
|
1.9 (left)
|
Nodular hyperplasia
| |
|
8
|
F
|
L
|
2.15 (left)
|
Papillary CA
| |
|
9
|
F
|
R
|
2.3 (right)
|
Papillary CA
| |
|
10
|
F
|
L
|
2.4 (midline)
|
Follicular adenoma
| |
|
11
|
F
|
L
|
2.7 (left)
|
Micropapillary CA
| |
|
12
|
F
|
L
|
3 (left)
|
Papillary CA
| |
|
13
|
F
|
L
|
1.7 (left)
|
Papillary CA
| |
|
14
|
F
|
L
|
3.5 (left)
|
Nodular hyperplasia
| |
|
15
|
F
|
R
|
Irregular, >3a
|
Papillary CA
|
ETE, PNI, LVI
|
|
16
|
M
|
L
|
5.5 (left)
|
Papillary CA
| |
|
17
|
F
|
L
|
6.5 (left)
|
Nodular hyperplasia
| |
|
18
|
F
|
R
|
7.7a(right)
|
Papillary CA
| |
|
19
|
M
|
L
|
9.1 (left)
|
Papillary CA
|
ETE, LVI
|
|
20
|
F
|
L
|
7 (left)
|
Nodular hyperplasia
| |
|
21
|
M
|
L
|
0.7 (left)
|
Micropapillary CA
| |
|
22
|
F
|
L
|
No imagingc
|
Osteosarcomab
| |
|
23
|
F
|
R
|
1.5 (right)
|
Papillary CA
| |
|
24
|
F
|
L
|
No imagingc
|
Poorly differentiated CA
| |
|
25
|
F
|
L
|
No imagingc
|
Papillary (tall cell variant) CA
|
ETE, PNI, LVI
|
- (M male, F female, U/S ultrasound, CA carcinoma, ETE extrathyroidal extension, PNI perineural invasion, LVI lymphovascular invasion)
-
aMeasure obtained from a CT Scan. No U/S available for this patient
-
bSee discussion section regarding this finding
-
cThese patients did not have preoperative imaging as they arrived in respiratory distress
